3D Cell Culture Companies and Market Forecast
The global 3D cell culture market was estimated at US$ 2.10 billion in 2023 and is projected to grow to US$ 7.02 billion by 2034, rising at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2034.
Top Companies in the 3D Cell Culture include:
- Thermo Fisher Scientific, Inc.
- Lena Biosciences
- PromoCell GmbH
- Merck KGaA
- Corning Incorporated
- REPROCELL Inc.
- Tecan Trading AG
- Avantor, Inc.
- Lonza
- HiMedia
- CN Bio Innovations Ltd
Recent Launch by Himedia in the 3D Cell Culture Market
| Company Name | HiMedia |
| Headquarters | Maharashtra, India, Asia Pacific |
| Recent Development | In June 2024, a renowned biotechnology business in Mumbai, HiMedia Laboratories, announced the opening of its cutting-edge Center of Excellence (CoE) for 3D Cell Culture Laboratory. With regard to HiMedia's dedication to promoting cooperative relationships and scientific research in the fields of 3D cell culture and bioprinting, this facility marks a noteworthy turning point. |
Recent Launch by Cell Microsystems in the 3D Cell Culture Market
| Company Name | Cell Microsystems |
| Headquarters | North Carolina, U.S., North America |
| Recent Development | In February 2024, the famous German cell biology business OMNI Life Science (OLS) and Cell Microsystems, a leading supplier of cutting-edge instruments for cell biology, are thrilled to announce a strategic cooperation. Through this partnership, life science research in North America will advance significantly as three ground-breaking products—the CERO, CASY, and TIGR—are brought to the US and Canadian markets. In order to produce specific 3D cell culture models, such as stem cells, spheroids, organoids, and even tissues, the CERO 3D is a novel and innovative device that generates an ideal cell culture environment. |
Latest Announcements by Industry Leaders
Eric Perreault, CEO of Kiyatec, Inc., was appointed as the new CEO of Kiyatec, Inc., a leading biotechnology company specializing in 3D cell culture technology. He envisions driving the company toward truly revolutionizing cancer care, especially for brain cancer patients, using 3D cell culture technology, ultimately improving patient outcomes.
Recent Developments in the 3D Cell Culture Market
- In August 2024, Cell Microsystems, a pioneer in cutting-edge instruments for cell biology, announced the growth of its internal contract research lab services. Using their cutting-edge CellRaft® Technology, these services include the generation of cell lines, bespoke organoids, and tests.
- In June 2024, Predictive Oncology, a biologics and drug discovery business, introduced its 3D cell culture model to help find new cancer treatments and expedite future drug development. In vitro organ and disease-specific models have been created by Predictive Oncology to precisely mimic the physiological milieu of human tissue.
- In June 2023, Nova Scotia's Halifax 3DBLeading tissue engineering inventor ioFibR announced the release of two new collagen fiber products: CollaFibRTM 3D scaffold and μCollaFibRTM (called micro-CollaFibRTM). Produced utilizing 3D BioFibR's unique and innovative dry-spinning technique to generate collagen fibers on a commercial scale, these readily available materials have noteworthy benefits for tissue engineering and tissue culture uses.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking